logo
Alvernia University's health center project receives gift from Breidegam Family Foundation

Alvernia University's health center project receives gift from Breidegam Family Foundation

Yahoo25-04-2025

Alvernia University has received a gift from the Breidegam Family Foundation to help turn the former American House into a state-of-the-art community-based health center in downtown Reading.
The center, in partnership with Berks Community Health Center, will provide health care to Reading's underserved populations and experiential learning opportunities for Alvernia students, officials said in a release.
Alvernia did not disclose the amount of the foundation's gift. Officials have said the renovation project will cost $17 million.
'The generous support from the Breidegam Foundation is pivotal in transforming our vision for the American House at Reading CollegeTowne into reality,' said Dr. Glynis A. Fitzgerald, Alvernia president. 'This initiative strengthens Alvernia's commitment to serving underserved communities and enhances experiential learning opportunities for our students across healthcare, social services, education, and other academic programs. We are deeply grateful for this investment in the well-being of our neighbors and the future of our region's workforce and nonprofit sector.'
The former American House at Fourth and Penn streets is, across the street from Alvernia's Reading CollegeTowne campus.
Alvernia University has received a gift from the Breidegam Family Foundation to help turn the former American House into a state-of-the-art community-based health center in downtown Reading. From left are Paula Barrett, Breidegam Family Foundation president; Dan Miksiewicz; Katelyn Miksiewicz-Kline; Dr. Glynis A. Fitzgerald, university president; Dr. Karen Wang, Berks Community Health Center chief medical officer; Matt Miksiewicz; and Thomas Minick, university vice president of advancement and government affairs.
In recognition of the gift, the second floor of the center will be named the Helen and DeLight Breidegam Center at the American House. DeLight Breidegam, who died in August 2021, was a co-founder of East Penn Manufacturing Co. Inc. in Richmond Township.
Officials said the gift comes as the university enters the final year of the five-year Partners in Progress campaign to build stronger communities by redefining higher education.
'The Breidegam Family Foundation is proud to support this initiative, which will have a lasting impact on healthcare access in Reading,' said Paula Barrett, President of the Breidegam Family Foundation. 'This project embodies the values of community service, innovation, education and collaboration, all of which were deeply important to our founders.'
Alvernia bought the 45,000-square-foot, four-story building at 354 Penn St. in June 2022 as part of its Reading CollegeTowne initiative.
The redeveloped building will create a multifaceted health care hub, featuring a new BCHC community health center that will host at least 50 annual clinical experiences for Alvernia occupational therapy, physician associate, physical therapy, exercise science, athletic training, nursing, social work, and addictions and mental health treatment students, officials said.
They said the project will respond to the city's urgent need for accessible health care, noting 27% of Reading residents live below the poverty line. BCHC will be able to serve 2,000 additional patients annually at the center, ensuring they have access to primary care, mental health, addiction counseling and other services-regardless of their ability to pay.
'This project will greatly impact the health care needs of the residents of the city of Reading,' Mary Kargbo, president and CEO of Berks Community Health Center, said in the release. 'By adding this location in the heart of downtown, we are increasing access to care in our quest for a healthier community while also strengthening the pipeline of future health care professionals.'
The third and fourth floors are planned to be renovated for additional business incubator space for the O'Pake Institute for Economic Development and Entrepreneurship and retail space for businesses.
Alvernia said it continues to seek philanthropic support for the project so construction can begin this year. The amount raised so far for the project was not immediately available.
Alvernia announced in November that it had received a $3 million state grant to support health care center project and the conversion of a former grocery store in Pottsville in to a CollegeTowne campus.
In January 2024, the Wyomissing Foundation awarded Alvernia a $300,000 grant toward the health center.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Reality star panics after gaining 20lbs when weight loss drug stopped working
Reality star panics after gaining 20lbs when weight loss drug stopped working

Daily Mail​

time15 minutes ago

  • Daily Mail​

Reality star panics after gaining 20lbs when weight loss drug stopped working

The use of weight loss drugs like Ozempic and Wegovy has surged in recent years. But the medications are not foolproof, as evidenced by a reality television star who just revealed hers 'stopped working.' Dolores Catania, 54, appeared on the June 6 episode of Jeff Lewis' eponymous SiriusXM show, where she revealed she's gained 20lbs. 'I'm having a really hard time right now. My Mounjaro stopped working. I gained 20 lbs,' the Real Housewives of New Jersey personality shared. 'I've been looking for therapy for all my friends. I'm really having a bad time with this,' she said while on the show with co-star Margaret Josephs. GLP-1 prescriptions are FDA-approved and are often prescribed to people with diabetes. Mounjaro's main component is tirzepatide, while Ozempic and Wegovy are brand names for semaglutide. The drugs improve satiety, reducing appetite and optimizing how the body processes sugar and fat, according to MayoClinic. Catania initially dropped weight using the medication, but has now gained it back. When asked if switching her medicine could be helpful, she replied, 'I did it all.' She explained that she's no longer taking Mounjaro due to having a cardiac ablation to correct her abnormal heart rhythm. The Bravo star said she's doing 'fine' now: 'I'm on a bunch of medicine, like, 10 pills a day. It's just a formality now. I have to take it for the next 90 days, then I should be done.' And she added, 'Maybe that's why I gained weight. I'm hoping maybe that's why.' Catania was among the first crop of celebrities who openly admitted to using one of the three popular weight loss drugs. After two years of taking it, she said in a February Hello! magazine interview: 'I know it's time for me to wean myself off or go on a lower dose.' Catania weighed 157lbs when she started taking the GLP-1 medication, starting with Ozempic before switching to Mounjaro. She cautioned that anyone considering the medications 'must always go through a real doctor, who knows what they are doing.' 'Research is everything,' she emphasized. The mother-of-two added that the medicine was 'a life changer' for her and boyfriend Paul Connell, who lost 60 pounds. She shared: 'He no longer takes a certain blood pressure medication, and it's been really positive. There are side effects like nausea, but you take a pill for that.' Other stars who have been candid about turning to the weight loss support of Ozempic, Mounjaro, and Wegovy include Amy Schumer, Oprah, and Eric Stonestreet.

Kirk Cousins sounds resigned to his sad Falcons fate
Kirk Cousins sounds resigned to his sad Falcons fate

New York Post

time15 minutes ago

  • New York Post

Kirk Cousins sounds resigned to his sad Falcons fate

Kirk Cousins might have already accepted his football fate. Cousins was at the Falcons' mandatory minicamp on Tuesday and seemed to know that his days as a starting quarterback in the NFL might be over. 'Obviously, you'd love to play,' Cousins told reporters. 'But I'm not gonna dwell on things that aren't reality.' Advertisement Cousins, 36, is coming off one of his worst seasons in the league in his 13-year career. He started in 14 games for the Falcons, throwing 18 touchdowns and 16 interceptions with a QBR of 50.4 Advertisement His season came to an end after being benched for rookie quarterback Michael Penix Jr. in week 16, as the Falcons missed out on the playoffs. It's expected that Cousins will become Penix's backup this year, as Atlanta might be left with the 36-year-old quarterback at the start of the 2025 season. Many thought the Falcons would wait until the June 1 deadline to cut the $180 million quarterback, but that deadline has come and gone, and Cousins is still in Atlanta. 3 Kirk Cousins at Falcons minicamp. AP Advertisement That leaves the only option for both parties — a trade. Nevertheless, even that seems less likely with each passing day. 3 Kirk Cousins and Michael Penix Jr. together at Falcons minicamp. AP The Steelers were the last team that desperately needed a quarterback but now have their guy in Aaron Rodgers. Advertisement Cousins said he's not looking at the past and hopes the Falcons have success this year. 3 Kirk Cousins in action at Falcons minicamp. AP 'Certainly there were conversations in January, February, March, even April, but we're moving forward now,' Cousins added. 'Those are things we talked about months ago. Now we need to move forward. Right now, it's about the situation I'm in and being the best I can be and hopefully, in February, we as an organization are holding up the Lombardi Trophy.'

ColonBroom GLP-1 Booster Website Updated to Highlight Daily Supplement for Metabolic Health
ColonBroom GLP-1 Booster Website Updated to Highlight Daily Supplement for Metabolic Health

Yahoo

time15 minutes ago

  • Yahoo

ColonBroom GLP-1 Booster Website Updated to Highlight Daily Supplement for Metabolic Health

New website update showcases natural GLP-1 support supplement designed to curb cravings, support metabolism, and promote healthy weight management SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- ColonBroom, a U.S.-based wellness brand, has announced a new update to its official website to highlight the launch of ColonBroom GLP-1 Booster—a daily supplement formulated to support metabolic function, appetite regulation, and overall weight wellness. Now available across the United States, the product offers a natural, lifestyle-friendly solution backed by science-supported ingredients. According to the official product website ( ColonBroom GLP-1 Booster is designed to work alongside the body's internal systems by promoting satiety, curbing cravings, and supporting blood sugar balance. The formula targets key wellness goals like reducing excess visceral fat and helping users manage weight more effectively without relying on restrictive diets or intense routines. 'ColonBroom GLP-1 Booster reflects our mission to simplify wellness with natural tools that align with modern lifestyles,' said a company spokesperson. 'This formula is designed with purpose—combining evidence-backed ingredients for those seeking real metabolic support.' The formulation includes Berberine, Chromium Picolinate, 5-HTP, Saffron Extract, and Bupleurum Root Extract—ingredients selected for their known roles in supporting GLP-1 activity, blood sugar balance, mood regulation, and fat metabolism. ColonBroom confirms that all supplements are manufactured in facilities that adhere to rigorous quality and safety protocols. The brand offers a satisfaction guarantee for new customers and invites visitors to explore ingredient insights, customer FAQs, and personalized quiz recommendations directly on the website. About ColonBroom ColonBroom is a San Francisco-based wellness brand dedicated to creating clean, effective, and easy-to-use daily supplements. With a focus on transparency and science-backed simplicity, ColonBroom empowers adults to take proactive steps toward digestive and metabolic wellness. Product and Contact Information Brand: ColonBroomWebsite: hello@ (Order Support): 1-888-505-0855Mailing Address: 505 Montgomery Street, 10th & 11th Floors, San Francisco, California, 94111, USA Disclaimer This release is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. The statements made about this product have not been evaluated by the Food and Drug Administration. Individual results may vary. Consumers should consult a qualified healthcare provider before beginning any new dietary supplement. CONTACT: Email: hello@ Phone (Order Support): 1-888-505-0855Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store